TrialMitochondrion2018

Development of a novel observer reported outcome tool as the primary efficacy outcome measure for a rare disease randomized controlled trial.

Peter W Stacpoole et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.